Skip to main content
Martha Arellano, MD, Hematology, Atlanta, GA, Emory University Hospital

MarthaLArellanoMD

Hematology • Atlanta, GA

Hematologic Oncology

Professor, Fellowship Program Director, Hematology and Medical Oncology, Winship Cancer Institute of Emory University

Join to view full profile

Dr. Arellano is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Arellano's full profile

Already have an account?

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2003 - 2006
  • Emory University School of Medicine
    Emory University School of MedicineResidency, Internal Medicine, 2000 - 2003
  • Emory University School of Medicine
    Emory University School of MedicineClass of 2000

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2003 - 2025
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Venetoclax Combined with Decitabine or Azacitidine in Treatment-Naive, Elderly Patients with Acute Myeloid Leukemia  
    Brian A Jonas, Courtney D DiNardo, Olga Frankfurt, Daniel A Pollyea, Keith Pratz, Anthony Letai, Martha Arellano, Marina Konopleva, Hagop M Kantarjian, Blood
  • Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML  
    Daniel A Pollyea, Amir T Fathi, Geoffrey L Uy, Robert K Stuart, Mikkael A Sekeres, Courtney D DiNardo, Alice S Mims, Eyal C Attar, Richard M Stone, Hagop M Kantarjian,..., The New England Journal of Medicine

Abstracts/Posters

  • Precision Medicine Treatment in Older AML: Results of Beat AML Master TrialClinically Relevant Abstract
    Martha L. Arellano, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Outcomes after Stem Cell Transplant in Older Patients with Acute Myeloid Leukemia Treated with Venetoclax-Based TherapiesClinically Relevant Abstract
    Martha L. Arellano, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Flotetuzumab, an Investigational CD123 x CD3 Bispecific Dart¬ Protein, in Salvage Therapy for Primary Refractory and Early Relapsed Acute Myeloid Leukemia (AML) Patients
    Martha L. Arellano, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Relationships and Stem Cells Made the Difference for This Leukemia Survivor
    Relationships and Stem Cells Made the Difference for This Leukemia SurvivorSeptember 20th, 2021
  • OncLive® Presents State of the Science Summit™ on Hematologic Malignancies
    OncLive® Presents State of the Science Summit™ on Hematologic MalignanciesOctober 31st, 2019
  • Winship Hematology and Medical Oncology Chief Fellow Receives Inaugural Khoury Award
    Winship Hematology and Medical Oncology Chief Fellow Receives Inaugural Khoury AwardJune 22nd, 2018
  • Join now to see all

Professional Memberships

Other Languages

  • Spanish

Hospital Affiliations

Dr. Martha Arellano, Dr. Martha Arellano, MD, Dr. M Arellano, Dr. Martha L Arellano